BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Sep 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-09-09

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-09	Common Stock	M	20000	$21.51	Acquired	82262	Direct
2013-09-09	Common Stock	S	20000	$73.00	Disposed	62262	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-09	Stock Option (right to buy) Common Stock	$21.51	M	20000	Disposed	2020-05-11	Common Stock (20000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 4, 2013.

F2: Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th day of every month thereafter.

F3: Reflexts number of sock options outstanding after the transactionn from this specific sotck option grant.